CBD, short for cannabidiol, is one of more than 120 chemical compounds or cannabinoids that are present in the Cannabis Sativa plant. CBD oil is derived from one specific type of cannabinoid.
Although cannabis has had a long history of medicinal usage all across the globe, it wasn't until recently that it became a part of mainstream medicine. It has had a controversial history. Most of the controversy around CBD has been due to its close association with marijuana, even though cannabidiol carries no psychoactive properties whatsoever due to the absence of THC content.
The FDA has laid out strict guidelines on what type of plants to use for the CBD extraction process and for making CBD-derived products. As per the guidelines, only hemp crops can be used for this purpose, which has gone through rigorous testing and carries no more than 0.3% THC content. This is to avoid any mind-altering effects of the product.
Speaking of hemp, Industrial Hemp Farms happens to be the leading name that grows and sells hemp and hemp-derived products on a large scale.
National Geographic ran a story back in 2015 on Siberian burial mounds dating back to 3,000 BC that contained charred traces of cannabis seeds.
Cannabis is also a prominent part of Chinese medicine that has been functional for thousands of years. The article further explained how our founding fathers also used cannabis. George Washington, in particular, grew it on his plantation estate in Mount Vernon.
However, due to its close association with its psychoactive sibling THC, cannabis has had a tumultuous past. That is why the positive and medicinal aspects of cannabis and CBD have been overshadowed by marijuana's mind-altering properties.
However, it is slowly becoming a part of mainstream medicine and gaining more and more acceptance. That’s apparent from the fact that not so long ago, the FDA approved the first-ever CBD-based medicine designed to treat epilepsy, called Epidiolex.
Can You Use CBD for Pain Management?
In one word, the answer is—absolutely. In fact, pain management continues to remain the leading reason behind CBD’s growing popularity. Many suffering from chronic pains and aches resort to CBD as a natural and holistic way of easing the discomfort without relying on harmful pills and drugs.
CBD oil helps manage pain by interacting with the cannabinoid receptors that are present throughout the body but also in the brain. It interacts with the Endocannabinoid System of the body to render those effects.
Many studies highlight the link between cannabis usage and relief from the side-effects of chemotherapy treatments as well.
Another study that was sponsored by National Institutes Health looked into the role of cannabis in relieving the symptoms of below-mentioned conditions:
Spinal cord injuries
Most localized pains
There’s a drug called Sativex, which is sold both in Canada and the UK. It’s made by combining CBD and THC. However, most experts feel it’s the presence of CBD that renders the anti-inflammatory properties to fight against the pain.
What Studies Have to Say About CBD’s Pain Management Properties
There’s a study by the European Journal of Pain that observed rats with arthritis and how they responded to CBD. The research observed the rats for four consecutive days during which CBD was applied topically. They observed a significant drop in signs of pain and inflammation in rats.
Here’s another promising clinical mention that talks about CBD’s effects on adults with Multiple Sclerosis. It mentions that short-term usage of CBD could reduce MS-related spasticity.
How to Use CBD?
You can get CBD into your system in a variety of ways. The first one is:
You can grab CBD capsules. Since they come pre-measured and pre-dosed, they are much more convenient to consume. You can start with a small dose and slowly increase it until you find something that works the best for you.
You can also get CBD in the form of tincture. It’s basically CBD in liquid form that comes with a dropper. Use the dropper to place a few drops underneath your tongue and let it sit for about a minute. The tincture helps you accurately measure your dose and find out which one works the best for you.
CBD is also available in the form of edible gummies. You can think of these as regular gummy bears, only they are laced with CBD. Not only are they a delicious way of getting CBD in your system, but they also come in a range of interesting flavors.
Sidenote: This method of CBD consumption is ideal if you’re aiming for systemic anti-inflammatory effects, meaning you need to experience the effects on your entire body.
This method is the best if you need pain relief from localized pains such as backache or sore knees. As the name suggests, it involves the direct application of CBD creams and oils on the affected area.
Since this method bypasses the digestive tract, it’s much easier to be absorbed by the body. It enters the bloodstream rapidly through the skin and shows quick effects.
With the introduction of Epidiolex, CBD’S popularity has soared, and it’s gaining more acceptance. More people are aware of its therapeutic side. The number of people who used to look down on CBD is reducing significantly by the day, which is good news.
But we need more solid research to back CBD’s health claims for a more mainstream and accepted usage on a wider scale. There’s also a strong need for awareness about cannabidiol’s holistic aspects.
Pot stock turbulence is nothing new, but the last few months have been particularly unpredictable for this sector. Many cannabis companies are seeing growth, but none seem to be a sure-fire winner that can provide …
In comparison to an outright disappointing 2019, pot stocks have done fairly well so far this year, all things considered. The coronavirus has sent a shockwave through retail markets, but cannabis has managed to work …
As opposed to 2019, which was largely a disaster for cannabis stocks, 2020 has been somewhat of a mixed bag. Cannabis consumption is up, but the market is flooded, so turning a profit remains difficult. …
The coronavirus pandemic has not been a particularly great time for most stocks, and in this regard, popular cannabis stocks are no exceptions either. Many pot stocks have recorded steep declines over the past months, …
By accessing PotStockNews.com (hereinafter referred to as “this website”) you hereby affirmatively represent to Market Jar Media Inc. (“Market Jar”) that you have read and understood the entirety of the following statements and policies
If you do not agree to these Statements & Policies, you may not use the PotStockNews.com website and affirmatively acknowledge that you have not used or viewed content on the PotStockNews.com website
Market Jar is neither an investment advisor nor broker-dealer. The information presented on the PotStockNews.com website is provided for informative purposes only and is not to be treated as a recommendation to make any specific investment. No such information on PotStockNews.com constitutes advice easeor a recommendation.
The opinions and analyses included in this website are based on factual information obtained from public filings and other sources deemed to be reliable and are provided “as is” in good faith. Market Jar makes no representation or warranty, expressed, implied or statutory, as to the accuracy or completeness of such information, which may be subject to change without notice.
Safe Harbor Statement
This website contains forward-looking statements applicable to future anticipated performance, growth, and plans of the companies on whose behalf we disseminate information. As such, any specific statement on this website that are not statements of factual history should be viewed as forward-looking statements. These forward-looking statements can be generally identified through phrases such as “possibly”, “anticipates”, “estimates”, “potentially”, “intends”, and other words of similar connotation. Statements in this website that speak to a company’s business intentions, objectives, strategies, and or intentions should also be viewed as forward-looking statements. All forward-looking statements are subject to uncertainties that could result in different outcomes than those described in forward-looking statements.
By accessing this website, you indicate your agreement to these Statements & Policies. You affirmatively represent that you have read and understood the entirety of the following Statements & Policies. We reserve the right, at our discretion, to change, modify, and add or delete portions of such Statements & Policies at any time.
The entire contents of this site are protected by worldwide copyright laws and treaty provisions. The contents of this website are for non-commercial individual reference only and may not be used for other purposes or otherwise copied, displayed, downloaded, distributed, modified, reproduced, republished or retransmitted without the express written consent of Market Jar.
Information subject to change
Information on this website is updated regularly by Market Jar without notice. However, the information is not intended to be complete and cover all matters and developments concerning the company and its activities and the company cannot guarantee either the currency or completeness of the information at all times and assumes no responsibility in this regard.
All stock quotes are delayed at least 15 minutes unless otherwise noted. All stock quotes or cryptocurrency price quotes (collectively “Quotes”) and historical price data are provided by a third party service provider and are provided for information purposes only and not for trading purposes. Market Jar makes no representation or warranty regarding the accuracy or completeness of any Quotes or historical price data and has not verified the adequacy, accuracy or completeness of the information provided on this website. We strongly recommend that you seek independent professional advice before investing in any companies, stock or cryptocurrency mentioned in the articles on the website.
Notice to investors
The information on this website is not intended as a solicitation for funds or an offering of securities and should not be construed or interpreted as such. The information on this website is not intended to modify, qualify, supplement or amend information disclosed under applicable securities legislation of the U.S. or Canada. No securities commission or other regulatory authority in either the U.S. or Canada has in any way passed upon the information on this website and Market Jar makes no representation or warranty to that effect.
Market Jar supports the use of social media, however any third party content posted through social media channels maintained by us should not be taken as an endorsement of such information. Links to websites and other resources operated by third parties (“Third Party Information”) other than Market Jar are provided solely as a convenience to the user. We do not control such Third Party Information and are not responsible and disclaim any liability for the content, products, services or information offered by any third parties. The inclusion of links to such Third Party Information on the page does not imply endorsement of any content, products or services offered, advertised, endorsed or promoted by any third party, or of any company or person. If you decide to access any Third Party Information or acquire any third party products or services, you do so entirely at your own risk, and you may be subject to the terms and conditions and the privacy policies imposed by such third parties. Third party sources generally state that the information contained therein has been obtained from sources believed to be reliable, but there can be no assurance as to the accuracy or completeness of included information. Although believed to be reliable, management of Market Jar has not independently verified any of the data from third party sources.
Ownership and Interests
PotStockNews.com is owned by Market Jar. Market Jar, and its directors and officers do not own any of the stocks mentioned in this article.
Amounts Paid To Market Jar Media Inc.
Market Jar Media Inc. has or expects to receive the following amounts indirectly from the issuer’s set forth below.
Sponsored Posts = $197 USD
Press Release = $197 USD
Amounts noted above were received or expected to be received directly from Market Jar Media Inc., which was directly engaged by the issuers set forth above.
Neither Market Jar nor its owners, members, officers, directors, partners, consultants, nor anyone involved in the publication of this website, is a registered investment advisor or broker-dealer or associated person with a registered investment advisor or broker-dealer and none of the foregoing make any recommendation that the purchase or sale of securities of any company or any cryptocurrency on the PotStockNews.com website is suitable or advisable for any person or that an investment or transaction in such securities will be profitable. Therefore, information on this website is not intended to be, and shall not substitute, an offer to sell nor the solicitation of any offer to buy any security.
The opinions and analysis included in this website related to the profiled companies represent the personal and subjective views of the author of the articles, and are subject to change at any time without notice. The information provided in the articles on the website and the content has been obtained from sources which the authors believe to be reliable. However, the authors have not independently verified or otherwise investigated all such information. None of the authors, Market Jar, Market Jar Media Inc., or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The opinion, analysis, articles and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission, the Canadian security regulatory authorities, or any other regulatory authority before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
Information obtained from public filings and other sources are deemed reliable; however, Market Jar take no responsibility for verifying the accuracy of such information and makes no representation that such information is complete and correct. Market Jar makes no representation or guarantee that any forward-looking statements will prove to be accurate. Persons using the PotStockNews.com website are encouraged to consult with independent financial advisors with respect to an investment in any company profiled in the website. Investors should therefore verify independently information provided in the PotStockNews.com website by completing their due diligence on any company in which their clients are contemplating an investment. Such information to be reviewed could include the company’s annual reports, regulatory filings, and press releases on the sec.gov or www.sedar.com website or directly from the issuer.
The content published on this website is intended for and only to be used for reference purposes and is neither an offer nor a solicitation to purchase or sell any security or instrument or to participate in any particular trading strategy. No such information provided through the PotStockNews.com website constitutes advice or a recommendation that any investment or trading strategy is suitable for any specific person. Users of this website agree that they are not using any content of this website in connection with an investment decision.
THERE CAN BE NO ASSURANCE THAT CONTENTS PUBLISHED ON POTSTOCKNEWS.COM IS ACCURATE OR WITHOUT ERROR. ANY PERSON WHO MAKES USE OF SUCH CONTENT AFFIRMATIVELY ASSUMES ALL RISKS FROM USING THE CONTENT. PotStockNews.com does not guarantee it reviews, and is not responsible for confirming the accuracy of information submitted for inclusion on this site. INVESTORS ARE STRONGLY ADVISED TO CONFIRM THE ACCURACY OF ANY INFORMATION OBTAINED FROM THIS SITE PRIOR TO MAKING ANY INVESTMENT DECISION.
OTC Risk Warnings
Because many securities traded Over-The-Counter (OTC) are relatively illiquid, or “thinly traded,” which tends to increase volatility in market prices, an investment in an OTC security involves a high degree of risk. These speculative and illiquid securities are often difficult for investors to buy or sell without significantly affecting the quoted price. It should be noted that the liquidation of a position in an OTC security may not even be possible within a reasonable period of time.
Dependable information regarding issuers of OTC securities, their prospects, or the risks associated with the business of any particular issuer or an investment in the issuer’s securities may not be available. For this reason, it may be difficult to properly value an investment in an OTC security or accurately determine the risks involved with investing in such a security. For more information about investing in microcap securities, please read the content on the SEC’s website, including the SEC’s investor publication titled “Microcap Stock: A Guide for Investors” available at https://www.sec.gov/investor/pubs/microcapstock.htm.
Issuers of OTC securities quoted on the OTC Link system are not required to provide any kind of information to investors. While many issuers register OTC securities with the Securities and Exchange Commission (SEC) and regularly provide reports to investors in connection with such registration, they are not required to continue such registration or regularly provide such reports because their securities are quoted on OTC Link. Securities may continue to be quoted on the OTC Link system if issuers are delinquent in their reporting obligation to the SEC or other federal or state regulatory agencies. Quotation of a security on the OTC Link system does not in itself create any ongoing filing or reporting obligations with the SEC for any issuer. In fact, issuers may not even be aware that their securities are quoted on the OTC Link system.
The information on this website has been prepared for information purposes only and does not constitute an offer to sell or trade, a solicitation to buy, or recommendation for any stock, security, cryptocurrency, ICO or related product, nor does it constitute an offer to provide investment advice or other related services by Market Jar Media Inc., or any of its principals, agents, owners, members or anyone else affiliated with the company, either expressly or indirectly. In preparing the information contained on this website, no individual financial or investment needs of the recipient have been taken into account nor is any financial or investment advice being offered. Any views expressed in on this website were prepared based upon the information available at the time such views were written. Changed or additional information could cause such views to change and Market Jar is under no obligation to provide notice of such information or update such views.